A

Ambrosia Bio

2 employees

Ambrosia Bio develops an enzyme technology platform that converts obesity-promoting sugars into minimal-calorie rare sugars.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Nutrition
Food Processing

Date founded

2020

Funding rounds raised

Total raised

$130K

from 1 investors over 1 rounds

A

Ambrosia Bio raised $130K on March 18, 2022

Investors: Brinc

FAQ